Evidence map›Paper›PMID 30765883›Full record

Trial reportEuropean journal of human genetics : EJHG2019

Using dried blood spot samples from a trio for linked-read whole-exome sequencing.

Ólavur Mortensen, Leivur Nattestad Lydersen, Katrin Didriksen Apol, Guðrið Andorsdóttir, Bjarni Á Steig, Noomi Oddmarsdóttir Gregersen

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ólavur MortensenFarGen, The Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands.
Leivur Nattestad LydersenFarGen, The Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands.
Katrin Didriksen ApolFarGen, The Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands.
Guðrið AndorsdóttirFarGen, The Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands.ORCID 0000-0003-1576-871X
Bjarni Á SteigGeneral Medical Department, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands.
Noomi Oddmarsdóttir GregersenFarGen, The Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands. noomi@fargen.fo.
University of the Faroe Islands · FO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term collection of dried blood spot (DBS) samples through newborn screening may have retrospective and prospective advantages, especially in combination with advanced analytical techniques. This work concerns whether linked-reads may overcome some of the limitations of short-read sequencing of DBS samples, such as performing molecular phasing. We performed whole-exome sequencing of DNA extracted from DBS and corresponding whole blood (WB) reference samples, belonging to a trio with unaffected parents and a proband affected by primary carnitine deficiency (PCD). For the DBS samples we were able to phase >21% of the genes under 100 kb, >40% of the SNPs, and the longest phase block was >72 kb. Corresponding results for the WB reference samples was >85%, >75%, and >915 kb, respectively. Concerning the PCD causing variant (rs72552725:A > G) in the SLC22A5 gene we observe full genotype concordance between DBS and WB for all three samples. Furthermore, we were able to phase all variants within the SLC22A5 gene in the proband's WB data, which shows that linked-read sequencing may replace the trio information for haplotype detection. However, due to smaller molecular lengths in the DBS data only small phase blocks were observed in the proband's DBS sample. Therefore, further optimisation of the DBS workflow is needed in order to explore the full potential of DBS samples as a test bed for molecular phasing.

Indexed as

Dried Blood Spot TestingExome SequencingGenome, HumanPolymorphism, Single NucleotideFemaleHumansMaleProspective StudiesRetrospective Studies

Identifiers

PMID30765883
PMCPMC6777531
OpenAlexW2912202610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.